Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019

Raymund R. Razonable; Eva M. Carmona; Paschalis Vergidis; John W. Wilson; William F. Marshall

doi:10.1016/j.mayocp.2020.05.037

Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019

Raymund R. Razonable, Eva M. Carmona, Paschalis Vergidis, John W. Wilson, William F. Marshall

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	S23-S25
Journal	Mayo Clinic proceedings
Volume	95
Issue number	9
DOIs	https://doi.org/10.1016/j.mayocp.2020.05.037
State	Published - Sep 2020

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/j.mayocp.2020.05.037

Cite this

@article{6ca8c88b576d4bd395174e1c54cac52d,

title = "Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019",

author = "Razonable, {Raymund R.} and Carmona, {Eva M.} and Paschalis Vergidis and Wilson, {John W.} and Marshall, {William F.}",

note = "Funding Information: Potential Competing Interests: Dr Razonable has received grants/grants pending for clinical trials from F. Hoffmann-La Roche Ltd and Regeneron Pharmaceuticals Inc (funds paid to his institution). Dr Vergidis is/was a consultant for AbbVie Inc (funds paid to his institution) and has received payment for lectures from Pfizer Inc. The other authors report no competing interests.",

year = "2020",

month = sep,

doi = "10.1016/j.mayocp.2020.05.037",

language = "English (US)",

volume = "95",

pages = "S23--S25",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "9",

}

TY - JOUR

T1 - Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019

AU - Razonable, Raymund R.

AU - Carmona, Eva M.

AU - Vergidis, Paschalis

AU - Wilson, John W.

AU - Marshall, William F.

N1 - Funding Information: Potential Competing Interests: Dr Razonable has received grants/grants pending for clinical trials from F. Hoffmann-La Roche Ltd and Regeneron Pharmaceuticals Inc (funds paid to his institution). Dr Vergidis is/was a consultant for AbbVie Inc (funds paid to his institution) and has received payment for lectures from Pfizer Inc. The other authors report no competing interests.

PY - 2020/9

Y1 - 2020/9

UR - http://www.scopus.com/inward/record.url?scp=85089681291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089681291&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2020.05.037

DO - 10.1016/j.mayocp.2020.05.037

M3 - Short survey

C2 - 32829906

AN - SCOPUS:85089681291

SN - 0025-6196

VL - 95

SP - S23-S25

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 9

ER -

Clinical Guidance and the Delivery of Care for Patients With Coronavirus Disease 2019

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this